ADVITOS Intensive Care Therapy Nominated for the Deutscher Zukunftspreis 2026
17.09.2026 Medical technology innovation from Munich opens new perspectives for the treatment of multi-organ failure in intensive care Munich, 17 September 2026 – The team consisting of Dr Claus Jessen, Dr Tobias Bingold and Christoph Hüßtege has been nominated for the Deutscher Zukunftspreis 2026, the Federal President’s Award for Technology and Innovation. The nomination recognises
ADVITOS Intensive Care Therapy Nominated for the Deutscher Zukunftspreis 2026 Read More »